Stephan Ruetz

4.7k total citations · 2 hit papers
36 papers, 3.5k citations indexed

About

Stephan Ruetz is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Stephan Ruetz has authored 36 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Oncology and 9 papers in Cell Biology. Recurrent topics in Stephan Ruetz's work include Drug Transport and Resistance Mechanisms (12 papers), Cancer-related Molecular Pathways (9 papers) and Lipid Membrane Structure and Behavior (6 papers). Stephan Ruetz is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Cancer-related Molecular Pathways (9 papers) and Lipid Membrane Structure and Behavior (6 papers). Stephan Ruetz collaborates with scholars based in Switzerland, Canada and United States. Stephan Ruetz's co-authors include Piet Gros, Jeanette M. Wood, Jonathan R. Green, Jean Michel Foidart, Laetitia Devy, Vincent Castronovo, Karine Bonjean, Akeila Bellahcène, Philippe Gros and Pascal Furet and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Stephan Ruetz

36 papers receiving 3.4k citations

Hit Papers

Novel Antiangiogenic Effects of the Bisphosphonate Compou... 1994 2026 2004 2015 2002 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Ruetz Switzerland 23 2.0k 1.7k 416 368 340 36 3.5k
Kenjiro Sawada Japan 40 1.3k 0.7× 2.7k 1.6× 310 0.7× 52 0.1× 409 1.2× 137 5.0k
Gert Rijksen Netherlands 32 1.2k 0.6× 2.7k 1.6× 312 0.8× 24 0.1× 226 0.7× 151 4.2k
Seiji Mabuchi Japan 42 1.6k 0.8× 2.4k 1.4× 732 1.8× 25 0.1× 509 1.5× 192 5.7k
Gerrit Jan Schuurhuis Netherlands 38 1.4k 0.7× 2.0k 1.2× 209 0.5× 36 0.1× 207 0.6× 114 4.7k
Hitoshi Kiyoi Japan 46 2.1k 1.0× 4.4k 2.5× 88 0.2× 55 0.1× 252 0.7× 277 9.0k
Jacques Jolivet Canada 29 1.0k 0.5× 1.7k 1.0× 127 0.3× 30 0.1× 411 1.2× 91 3.9k
Raymond Taetle United States 38 1.2k 0.6× 2.2k 1.3× 183 0.4× 22 0.1× 267 0.8× 129 4.4k
Bruno Quesnel France 47 2.6k 1.3× 3.5k 2.0× 148 0.4× 59 0.2× 504 1.5× 202 8.1k
Soheil Meshinchi United States 49 1.4k 0.7× 4.2k 2.5× 55 0.1× 53 0.1× 369 1.1× 328 8.9k
Markus Y. Mapara United States 35 1.8k 0.9× 2.5k 1.5× 164 0.4× 25 0.1× 163 0.5× 174 5.0k

Countries citing papers authored by Stephan Ruetz

Since Specialization
Citations

This map shows the geographic impact of Stephan Ruetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Ruetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Ruetz more than expected).

Fields of papers citing papers by Stephan Ruetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Ruetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Ruetz. The network helps show where Stephan Ruetz may publish in the future.

Co-authorship network of co-authors of Stephan Ruetz

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Ruetz. A scholar is included among the top collaborators of Stephan Ruetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Ruetz. Stephan Ruetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaupel, Andrea, Philipp Holzer, Stéphane Ferretti, et al.. (2018). In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor. Bioorganic & Medicinal Chemistry Letters. 28(20). 3404–3408. 16 indexed citations
2.
Gessier, F., Joerg Kallen, Edgar Jacoby, et al.. (2015). Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53–MDM2 interaction with a distinct binding mode. Bioorganic & Medicinal Chemistry Letters. 25(17). 3621–3625. 47 indexed citations
3.
Holzer, Philipp, Keiichi Masuya, Pascal Furet, et al.. (2015). Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. Journal of Medicinal Chemistry. 58(16). 6348–6358. 152 indexed citations
4.
Massey, Andrew J., Joseph Schoepfer, Paul A. Brough, et al.. (2010). Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800. Molecular Cancer Therapeutics. 9(4). 906–919. 50 indexed citations
5.
McSheehy, Paul M.J., Claudia Weidensteiner, Catherine Cannet, et al.. (2009). Quantified Tumor T1 Is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell Viability. Clinical Cancer Research. 16(1). 212–225. 47 indexed citations
6.
Ruetz, Stephan, et al.. (2007). Cis‐Stilbene Derived Furopyranones Show Potent Antiproliferative Activity by Inducing G2/M Arrest. ChemMedChem. 2(4). 441–444. 5 indexed citations
7.
Beuvink, Iwan, Anne Boulay, Stefano Fumagalli, et al.. (2005). The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation. Cell. 120(6). 747–759. 426 indexed citations
8.
Garcı́a-Echeverrı́a, Carlos, Mark Pearson, Andreas Marti, et al.. (2004). In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell. 5(3). 231–239. 447 indexed citations
9.
Ruetz, Stephan, François Natt, Jonathan Hall, et al.. (2004). The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels. Experimental Cell Research. 303(2). 482–493. 22 indexed citations
10.
Beuvink, Iwan, Anne Boulay, Stefano Fumagalli, et al.. (2004). 40 RAD001 sensitizes tumor cells to cisplatin-induced apoptosis in an mTOR dependent manner by inhibition of p53-induced p21 protein expression. European Journal of Cancer Supplements. 2(8). 16–16. 1 indexed citations
11.
Ruetz, Stephan, Doriano Fabbro, Juerg Zimmermann, Thomas Meyer, & Nathanael S. Gray. (2003). Chemical and Biological Profile of Dual Cdk1 and Cdk2 Inhibitors. PubMed. 3(1). 1–14. 32 indexed citations
12.
Garcı́a-Echeverrı́a, Carlos & Stephan Ruetz. (2003). β-Homolysine Oligomers: A New Class of Trojan Carriers. Bioorganic & Medicinal Chemistry Letters. 13(2). 247–251. 19 indexed citations
13.
Ruetz, Stephan. (1998). [28] Yeast secretory vesicle system for expression and functional characterization of P-glycoproteins. Methods in enzymology on CD-ROM/Methods in enzymology. 292. 382–396. 5 indexed citations
14.
Sardini, Alessandro, Stephan Ruetz, Richard Callaghan, et al.. (1996). Protein Kinase C-mediated Phosphorylation Does Not Regulate Drug Transport by the Human Multidrug Resistance P-glycoprotein. Journal of Biological Chemistry. 271(23). 13668–13674. 110 indexed citations
15.
Ruetz, Stephan & Philippe Gros. (1995). Enhancement of Mdr2-mediated Phosphatidylcholine Translocation by the Bile Salt Taurocholate. Journal of Biological Chemistry. 270(43). 25388–25395. 75 indexed citations
16.
Raymond, Martine, Stephan Ruetz, David Y. Thomas, & Piet Gros. (1994). Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520. Molecular and Cellular Biology. 14(1). 277–286. 10 indexed citations
17.
Ruetz, Stephan. (1994). Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell. 77(7). 1071–1081. 509 indexed citations breakdown →
18.
Ruetz, Stephan & Philippe Gros. (1994). A mechanism for P-glycoprotein action in multidrug resistance: are we there yet?. Trends in Pharmacological Sciences. 15(7). 260–263. 44 indexed citations
19.
Ruetz, Stephan, M Raymond, & Philippe Gros. (1993). Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast cells.. Proceedings of the National Academy of Sciences. 90(24). 11588–11592. 41 indexed citations
20.
Ruetz, Stephan, Gert Fricker, G. Hugentobler, et al.. (1987). Isolation and characterization of the putative canalicular bile salt transport system of rat liver.. Journal of Biological Chemistry. 262(23). 11324–11330. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026